| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/2001 | EP1117395A1 Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| 07/25/2001 | EP1117394A1 Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 07/25/2001 | EP1117393A2 Use of acylcarnitines as antitumour agents |
| 07/25/2001 | EP1117392A1 Method for preventing or delaying catheter-based revascularization |
| 07/25/2001 | EP1117391A2 Methods for treating multiple sclerosis |
| 07/25/2001 | EP1117390A1 Mucosal originated drug delivery systems and animal applications |
| 07/25/2001 | EP1117389A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 07/25/2001 | EP1117388A1 Antioxidant gel for gingival conditions |
| 07/25/2001 | EP1117387A2 Coated medicament forms with controlled active substance release |
| 07/25/2001 | EP1117384A1 Controlled release nanoparticulate compositions |
| 07/25/2001 | EP1117383A1 Dosage form comprising therapeutic formulation |
| 07/25/2001 | EP1117378A2 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 07/25/2001 | EP1117373A1 Hair tonic |
| 07/25/2001 | EP1117372A2 Method of treating hair loss using sulfonamides |
| 07/25/2001 | EP1117371A2 Method of treating hair loss using ketoamides |
| 07/25/2001 | EP1117370A1 CONTROLLED RELEASE FROM COPOLYMERS OF ACRYLIC OR METHACRYLIC ACID/L-DOPA, ACRYLIC OR METHACRYLIC ACID/L-$g(a)-METHYL DOPA, ACRYLIC OR METHACRYLIC ACID/CARBIDOPA AND THEIR COMBINATIONS |
| 07/25/2001 | EP1117356A1 Methods and apparatus for improved administration of fentanyl and sufentanil |
| 07/25/2001 | EP1117297A1 Synthetic analogs of ecteinascidin-743 |
| 07/25/2001 | EP1117296A1 Combination of bisphosphonate and tetracycline |
| 07/25/2001 | EP1104653A9 Composition for animals containing a methyl salicylate |
| 07/25/2001 | EP0892785B1 Antimicrobial solution of formaldehyde substituted hydantoin and process for preparation |
| 07/25/2001 | EP0889876B1 Meta-substituted phenylene sulphonamide derivatives |
| 07/25/2001 | EP0879230B1 Optically active phenyl pyrimidine derivative as analgesic agent |
| 07/25/2001 | EP0876366B1 Angiogenesis inhibiting pyridazinamines |
| 07/25/2001 | EP0876346B1 Antimalarial quinolin derivatives |
| 07/25/2001 | EP0873319B1 Quinazoline derivatives |
| 07/25/2001 | EP0854860B1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 07/25/2001 | EP0814770B1 Process for the preparation of a solid pharmaceutical dosage form |
| 07/25/2001 | EP0794955B1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 07/25/2001 | EP0788487B1 Process for the preparation of tetrazoles |
| 07/25/2001 | EP0788362B1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 07/25/2001 | EP0783501B9 pyrimidone derivatives with antifungal activity |
| 07/25/2001 | EP0772610B9 Dihydrobenzofuranes |
| 07/25/2001 | EP0765322B1 Indole derivatives as prodrugs of 5-ht1-like receptor agonists |
| 07/25/2001 | EP0752857B1 AN IMPROVED METHOD OF SYNTHESIS FOR 6,9-BIS (2-AMINOETHYL)AMINO]BENZO g]ISOQUINOLINE-5,10-DIONE AND ITS DIMALEATE SALT |
| 07/25/2001 | EP0751760B1 Treatment of ultraviolet radiation-induced erythema |
| 07/25/2001 | EP0741709B1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists |
| 07/25/2001 | EP0739206B1 Composition for drug delivery comprising nicotine or a derivative thereof and starch microspheres and method for the manufacturing thereof |
| 07/25/2001 | EP0698612B1 Osteogenesis promoter and osteoporosis remedy |
| 07/25/2001 | EP0684944B1 Coupling product obtained from hystamine and an amino acid |
| 07/25/2001 | EP0677049B1 Quinazoline derivatives |
| 07/25/2001 | EP0585252B1 Pharmaceutical formulations |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305491A Crystalline forms of 1S-[1a(pha(2S, 3R), 9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]-amino] actahydro-6H-piridazino [1,2-A][1,2] diazepin-1-carboxamide |
| 07/25/2001 | CN1305489A Solid dispersion containing sialic acid derivative |
| 07/25/2001 | CN1305488A Testosterone derivative |
| 07/25/2001 | CN1305487A Benzo (b) thiepine-1, 1-dioxide derivatives, method for production thereof, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305486A Novel compounds derived from alpha-D-xylose, preparation method and therapeutic use |
| 07/25/2001 | CN1305485A Monomeric, oligomeric acid polymeric knoevenagel condensation products |
| 07/25/2001 | CN1305484A 3-(2-oxo[1,3']bihyrrolidinyl-3-ylidenemethyl)-cephems |
| 07/25/2001 | CN1305483A Polymorphic clopidogrel hydrogenesulphate form |
| 07/25/2001 | CN1305482A Artemisinin derivatives, method for preparation thereof and pharmaceutical compositions containing the same |
| 07/25/2001 | CN1305481A Piperazino derivatives as neurokinin antafonists |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305478A Pyrazolopyrimidinone cGMP PDE 5 inhibitors for treatment of sexual dysfunction |
| 07/25/2001 | CN1305477A Azablicyclic 5-HT, receptor ligands |
| 07/25/2001 | CN1305475A Chemical synthesis of morpholine derivatives |
| 07/25/2001 | CN1305474A Paroxetine maleate |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305471A Dihydropyrimidines |
| 07/25/2001 | CN1305470A Amidine compounds |
| 07/25/2001 | CN1305469A Benzothiepine-1, 1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 07/25/2001 | CN1305467A Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305463A Substituted sulphonyl cyanamides, method for producing same and their use as medicament |
| 07/25/2001 | CN1305462A Novel 1,5 and 3-O-substituted 1H-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, and method for the production and use thereof as medica |
| 07/25/2001 | CN1305460A Process for preparation of R-(+)-6-carboxamido-3-N-methylamino-1,2,3,4-tetrahydrocarbazole |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1305457A Novel antiestrogens, method for production thereof and their pharmaceutical application |
| 07/25/2001 | CN1305454A Anthranilic acid derivatives as inhibitors of CGMP phosphodiesterase |
| 07/25/2001 | CN1305449A Anti-inflammatory, antibacterial benzyl phenol agents |
| 07/25/2001 | CN1305387A Enhancement of antibody-cytokine fusion protein medicated immune responses by co-administration with prostaglandin inhibitor |
| 07/25/2001 | CN1305386A Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with angiogenesis inhibitor |
| 07/25/2001 | CN1305385A Method and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 07/25/2001 | CN1305382A Use of PEG-IFN-alpha and triazole nucleoside for treatment of chronic hepatitis C |
| 07/25/2001 | CN1305381A Cyclophosphamide coated tablets |
| 07/25/2001 | CN1305380A Use of composition comprising Formoterol and Budesonide for prevention or treatment of acute condition of asthma |
| 07/25/2001 | CN1305379A Method of treatment |
| 07/25/2001 | CN1305378A Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretagogues (GHS) for treating musculoskeletal fragility |
| 07/25/2001 | CN1305377A Methods for increasing levels of acetylcholine |
| 07/25/2001 | CN1305376A Pharmaceutical composition for treatment of diabetes |
| 07/25/2001 | CN1305375A Antibacterial agents |
| 07/25/2001 | CN1305374A Oxazolidinones to treat eye infections |
| 07/25/2001 | CN1305373A Therapeutic combinations comprising selective estrofen receptor modulator and parathyroid hormone |
| 07/25/2001 | CN1305371A Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 07/25/2001 | CN1305370A Bioactive glass treatment of inflammation in skin conditions |
| 07/25/2001 | CN1305369A Pharmaceutical aerosol formulation |
| 07/25/2001 | CN1305368A Implants for administering substances and methods of producing implants |
| 07/25/2001 | CN1305343A Methods for increasing levels of acetylchotine |
| 07/25/2001 | CN1305342A Methods for reducing levels of homocysteine and C-reactive protein |
| 07/25/2001 | CN1304936A Quinoline-4-radical derivative II |
| 07/25/2001 | CN1304934A Antineoplastic medicine and its preparing process |
| 07/25/2001 | CN1304930A Arylsulfurylisooximino acid derivative |
| 07/25/2001 | CN1304923A Preparing process and application of calcium levulinate |
| 07/25/2001 | CN1304767A Plaster for treating infantile parotitis and its preparing process |
| 07/25/2001 | CN1304764A Plant night cream for treating pustular acne |
| 07/25/2001 | CN1304762A Medicine for treating burn and scald |
| 07/25/2001 | CN1304759A Dermatitis ointment and its preparing process |